About
Medical Flowers Developments (MFD) is a Spanish biotech company developing cannabis medicated chewing gums as pharmacological support for behavioural addiction therapies.
The company is working on a new oral, single-dose, pharmaceutical-grade dosage form designed to deliver cannabinoids in a controlled manner through the buccal mucosa. The objective is to provide a complementary therapeutic tool to help manage anxiety peaks and craving that may occur during addiction treatment processes.
MFD’s first clinical program focuses on Cannabis Use Disorder (CUD), an unmet medical need with no approved pharmacological treatment today. Following this first validation, the company plans to explore the potential of its technology in other addictions, including cocaine, alcohol and opioids.
MFD is currently preparing Phase I clinical validation and is seeking partnerships with industrial partners, pharmaceutical companies, clinical centres and biotech/pharma investors interested in developing innovative medicines for addiction treatment.
Sector
Pharmaceutical industryHealth innovation